Paratek antibiotic not inferior to current treatments: FDA staff

Paratek antibiotic not inferior to current treatments: FDA staff

Source: 
Reuters
snippet: 

Paratek Pharmaceuticals Inc’s new antibiotic for bacterial pneumonia and skin infections is not inferior to current treatments, U.S. Food and Drug Administration staff reviewers said on Monday.